Mohammad Omar Butt

5PUBLICATIONS
22CO-AUTHORS
Pharmaceutical delivery technologiesCardiology (incl. cardiovascular diseases)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

|Jul 15, 2026
GLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis.

|Jun 26, 2026
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

|Jun 25, 2026
Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis.

|May 27, 2026
Comparative Effectiveness of Finerenone Versus SGLT2 Inhibitors in Patients with HFpEF and CKD: A Real-World Propensity-Matched TriNetX Analysis.

Pageof 1

Frequent Collaborators

5 joint publications

Najam Gohar

5 joint publications

Muhammad Hassan

5 joint publications

Haris Bin Tahir

4 joint publications

Saifullah Khan